Generex Biotechnology (GNBT) News Today

Bloomage Biotechnology
Generex Creates Own Regulatory Reality
Generex Plans Reverse Stock Split
Generex Biotechnology Jumps
Get Generex Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNBT and its competitors with MarketBeat's FREE daily newsletter.

The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)

Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …

Click here to see the presentation now.

GNBT Media Mentions By Week

GNBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GNBT
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

GNBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GNBT Articles
This Week

0

0

GNBT Articles
Average Week

Get Generex Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:GNBT) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners